JP2019203007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019203007A5 JP2019203007A5 JP2019131162A JP2019131162A JP2019203007A5 JP 2019203007 A5 JP2019203007 A5 JP 2019203007A5 JP 2019131162 A JP2019131162 A JP 2019131162A JP 2019131162 A JP2019131162 A JP 2019131162A JP 2019203007 A5 JP2019203007 A5 JP 2019203007A5
- Authority
- JP
- Japan
- Prior art keywords
- peak
- value
- crystal
- following
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013078 crystal Substances 0.000 claims 11
- 239000012453 solvate Substances 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016195505 | 2016-10-03 | ||
| JP2016195505 | 2016-10-03 | ||
| JP2017184731 | 2017-09-26 | ||
| JP2017184731 | 2017-09-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543858A Division JP6596697B2 (ja) | 2016-10-03 | 2017-09-27 | Ｔｒｈアナログ及びアルンド酸を組み合わせてなる組成物、並びにアルンド酸の薬学的に許容される塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019203007A JP2019203007A (ja) | 2019-11-28 |
| JP2019203007A5 true JP2019203007A5 (enExample) | 2020-11-12 |
Family
ID=61832036
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543858A Active JP6596697B2 (ja) | 2016-10-03 | 2017-09-27 | Ｔｒｈアナログ及びアルンド酸を組み合わせてなる組成物、並びにアルンド酸の薬学的に許容される塩 |
| JP2019131162A Pending JP2019203007A (ja) | 2016-10-03 | 2019-07-16 | Ｔｒｈアナログ及びアルンド酸を組み合わせてなる組成物、並びにアルンド酸の薬学的に許容される塩 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543858A Active JP6596697B2 (ja) | 2016-10-03 | 2017-09-27 | Ｔｒｈアナログ及びアルンド酸を組み合わせてなる組成物、並びにアルンド酸の薬学的に許容される塩 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10828303B2 (enExample) |
| EP (1) | EP3520795B1 (enExample) |
| JP (2) | JP6596697B2 (enExample) |
| KR (1) | KR20190065315A (enExample) |
| CN (2) | CN110267661B (enExample) |
| AU (1) | AU2017340594B2 (enExample) |
| BR (1) | BR112019006429A2 (enExample) |
| CA (1) | CA3039027A1 (enExample) |
| CO (1) | CO2019003255A2 (enExample) |
| IL (1) | IL265688A (enExample) |
| MX (1) | MX2019003837A (enExample) |
| PH (1) | PH12019500636A1 (enExample) |
| SG (1) | SG11201902599SA (enExample) |
| TW (1) | TW201818939A (enExample) |
| WO (1) | WO2018066427A1 (enExample) |
| ZA (1) | ZA201902341B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201907591D0 (en) * | 2019-05-29 | 2019-07-10 | Eolas Res Limited | Composition and use |
| IT202000015895A1 (it) | 2020-07-27 | 2022-01-27 | Univ Cattolica Del Sacro Cuore | L’impiego di acido arundico nella terapia della sclerosi multipla |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6223429A (ja) * | 1985-07-24 | 1987-01-31 | Ishikawajima Harima Heavy Ind Co Ltd | 水素同位体の回収・貯蔵・供給装置 |
| JPS62234029A (ja) * | 1985-12-27 | 1987-10-14 | Tanabe Seiyaku Co Ltd | 中枢神経賦活剤 |
| ATE163006T1 (de) | 1993-06-01 | 1998-02-15 | Ono Pharmaceutical Co | Pentansäurederivate |
| JPH0782166A (ja) | 1993-09-14 | 1995-03-28 | Tanabe Seiyaku Co Ltd | 抗ショック剤 |
| US9016221B2 (en) * | 2004-02-17 | 2015-04-28 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
| EP1741697B1 (en) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Crystal comprising (2r)-2-propyloctanoic acid and dibenzylamine |
| JP2006143708A (ja) * | 2004-10-19 | 2006-06-08 | Ono Pharmaceut Co Ltd | 神経変性疾患治療用医薬 |
| TWI680117B (zh) * | 2008-05-19 | 2019-12-21 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| PT2443120T (pt) * | 2009-06-16 | 2017-02-08 | Rspr Pharma Ab | Forma cristalina de pemirolast |
| CN102786414B (zh) * | 2012-08-15 | 2014-07-16 | 四川大学 | 一类用于治疗和/或预防神经退行性相关疾病的化合物 |
-
2017
- 2017-09-27 US US16/338,594 patent/US10828303B2/en active Active
- 2017-09-27 CN CN201780072845.3A patent/CN110267661B/zh active Active
- 2017-09-27 EP EP17858265.6A patent/EP3520795B1/en active Active
- 2017-09-27 WO PCT/JP2017/034926 patent/WO2018066427A1/ja not_active Ceased
- 2017-09-27 KR KR1020197011464A patent/KR20190065315A/ko not_active Ceased
- 2017-09-27 SG SG11201902599SA patent/SG11201902599SA/en unknown
- 2017-09-27 AU AU2017340594A patent/AU2017340594B2/en not_active Ceased
- 2017-09-27 MX MX2019003837A patent/MX2019003837A/es unknown
- 2017-09-27 JP JP2018543858A patent/JP6596697B2/ja active Active
- 2017-09-27 BR BR112019006429A patent/BR112019006429A2/pt not_active IP Right Cessation
- 2017-09-27 CA CA3039027A patent/CA3039027A1/en not_active Abandoned
- 2017-09-27 CN CN202110788643.7A patent/CN113559102B/zh active Active
- 2017-10-02 TW TW106133988A patent/TW201818939A/zh unknown
-
2019
- 2019-03-22 PH PH12019500636A patent/PH12019500636A1/en unknown
- 2019-03-28 IL IL265688A patent/IL265688A/en unknown
- 2019-04-01 CO CONC2019/0003255A patent/CO2019003255A2/es unknown
- 2019-04-12 ZA ZA2019/02341A patent/ZA201902341B/en unknown
- 2019-07-16 JP JP2019131162A patent/JP2019203007A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010516681A5 (enExample) | ||
| FI114913B (fi) | Menetelmä terapeuttisesti käyttökelpoisten furanonijohdannaisten valmistamiseksi ja menetelmässä käyttökelpoinen lähtöaine | |
| JP2013505929A5 (enExample) | ||
| JP2019203007A5 (enExample) | ||
| RU2009131727A (ru) | Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения | |
| JP2010530897A5 (enExample) | ||
| JP2012503016A5 (enExample) | ||
| JP2013512277A5 (enExample) | ||
| JP2009521414A5 (enExample) | ||
| RU2010145171A (ru) | Аналоги галихондрина в | |
| JP2020512316A5 (enExample) | ||
| WO1996005176A1 (en) | Fused pyridazine compound | |
| EP4567951A3 (en) | Solid electrolyte and method for producing same | |
| JP2007532560A5 (enExample) | ||
| JP2012149045A5 (ja) | ベンゾ［ｂ］ナフト［１，２−ｄ］フラン化合物 | |
| JP2010534246A5 (enExample) | ||
| JPS61502467A (ja) | メバロノラクトンのピラゾ−ル同族体およびその誘導体、それらの製造方法ならびに用途 | |
| JP2007519721A5 (enExample) | ||
| DE3805801C2 (de) | Antihypercholesterinämisch wirkende Tetrazol-Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Mittel | |
| JPWO2021199676A5 (enExample) | ||
| JP2013523706A5 (enExample) | ||
| JP2012528839A5 (enExample) | ||
| JP2010507590A5 (enExample) | ||
| JP2012528883A5 (enExample) | ||
| EA202191859A1 (ru) | Кристаллические формы 1-(1,2-диметилпропил)-n-этил-5-метил-n-пиридазин-4-ил-пиразол-4-карбоксамида |